Literature DB >> 22492159

Fatal Rocky Mountain spotted fever in the United States, 1999-2007.

F Scott Dahlgren1, Robert C Holman, Christopher D Paddock, Laura S Callinan, Jennifer H McQuiston.   

Abstract

Death from Rocky Mountain spotted fever (RMSF) is preventable with prompt, appropriate treatment. Data from two independent sources were analyzed to estimate the burden of fatal RMSF and identify risk factors for fatal RMSF in the United States during 1999-2007. Despite increased reporting of RMSF cases to the Centers for Disease Control and Prevention, no significant changes in the estimated number of annual fatal RMSF cases were found. American Indians were at higher risk of fatal RMSF relative to whites (relative risk [RR] = 3.9), and children less than 10 years of age (RR=5.1) [corrected] and adults ≥ 70 years of age (RR = 3.0) were also at increased risk relative to other ages. Persons with cases of RMSF with an immunosuppressive condition were at increased risk of death (RR = 4.4). Delaying treatment of RMSF was also associated with increased deaths. These results may indicate a gap between recommendations and practice.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22492159      PMCID: PMC3403778          DOI: 10.4269/ajtmh.2012.11-0453

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  34 in total

1.  Assessing the magnitude of fatal Rocky Mountain spotted fever in the United States: comparison of two national data sources.

Authors:  Christopher D Paddock; Robert C Holman; John W Krebs; James E Childs
Journal:  Am J Trop Med Hyg       Date:  2002-10       Impact factor: 2.345

2.  Rocky Mountain spotted fever in the United States, 1997-2002.

Authors:  Alice S Chapman; Staci M Murphy; Linda J Demma; Robert C Holman; Aaron T Curns; Jennifer H McQuiston; John W Krebs; David L Swerdlow
Journal:  Vector Borne Zoonotic Dis       Date:  2006       Impact factor: 2.133

3.  Rocky Mountain spotted fever in the USA: a benign disease or a common diagnostic error?

Authors:  Didier Raoult; Philippe Parola
Journal:  Lancet Infect Dis       Date:  2008-10       Impact factor: 25.071

4.  Fatal cases of Rocky Mountain spotted fever in the United States, 1981-1988.

Authors:  D B Fishbein; M G Frontini; R Giles; L L Vernon
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

5.  Doxycycline and staining of permanent teeth.

Authors:  M E Lochary; P B Lockhart; W T Williams
Journal:  Pediatr Infect Dis J       Date:  1998-05       Impact factor: 2.129

6.  Rocky mountain spotted fever in the United States, 2000-2007: interpreting contemporary increases in incidence.

Authors:  John J Openshaw; David L Swerdlow; John W Krebs; Robert C Holman; Eric Mandel; Alexis Harvey; Dana Haberling; Robert F Massung; Jennifer H McQuiston
Journal:  Am J Trop Med Hyg       Date:  2010-07       Impact factor: 2.345

7.  Fatal Rocky Mountain spotted fever.

Authors:  M A Hattwick; H Retailliau; R J O'Brien; M Slutzker; R E Fontaine; B Hanson
Journal:  JAMA       Date:  1978-09-29       Impact factor: 56.272

Review 8.  Aplastic anemia associated with parenteral chloramphenicol: review of 10 cases, including the second case of possible increased risk with cimetidine.

Authors:  B C West; G A DeVault; J C Clement; D M Williams
Journal:  Rev Infect Dis       Date:  1988 Sep-Oct

9.  Doxycycline use for rickettsial disease in pediatric patients.

Authors:  J J Purvis; M S Edwards
Journal:  Pediatr Infect Dis J       Date:  2000-09       Impact factor: 2.129

10.  Physician knowledge of the diagnosis and management of Rocky Mountain spotted fever: Mississippi, 2002.

Authors:  M O'Reilly; C Paddock; B Elchos; J Goddard; J Childs; M Currie
Journal:  Ann N Y Acad Sci       Date:  2003-06       Impact factor: 5.691

View more
  19 in total

Review 1.  Update on tick-borne rickettsioses around the world: a geographic approach.

Authors:  Philippe Parola; Christopher D Paddock; Cristina Socolovschi; Marcelo B Labruna; Oleg Mediannikov; Tahar Kernif; Mohammad Yazid Abdad; John Stenos; Idir Bitam; Pierre-Edouard Fournier; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

2.  Phylogeography of Rickettsia rickettsii genotypes associated with fatal Rocky Mountain spotted fever.

Authors:  Christopher D Paddock; Amy M Denison; R Ryan Lash; Lindy Liu; Brigid C Bollweg; F Scott Dahlgren; Cristina T Kanamura; Rodrigo N Angerami; Fabiana C Pereira dos Santos; Roosecelis Brasil Martines; Sandor E Karpathy
Journal:  Am J Trop Med Hyg       Date:  2014-06-23       Impact factor: 2.345

3.  Assessment of real-time PCR assay for detection of Rickettsia spp. and Rickettsia rickettsii in banked clinical samples.

Authors:  Cecilia Y Kato; Ida H Chung; Lauren K Robinson; Amy L Austin; Gregory A Dasch; Robert F Massung
Journal:  J Clin Microbiol       Date:  2012-11-07       Impact factor: 5.948

4.  Routine argyrophil techniques detect Rickettsia rickettsii in tissues of patients with fatal Rocky Mountain spotted fever.

Authors:  Christopher D Paddock; Jeanine H Sanders; Amy M Denison; Atis Muehlenbachs; Sherif R Zaki
Journal:  J Histotechnol       Date:  2016-12-12       Impact factor: 0.714

5.  Case report: Co-infection of Rickettsia rickettsii and Streptococcus pyogenes: is fatal Rocky Mountain spotted fever underdiagnosed?

Authors:  Gregory A Raczniak; Cecilia Kato; Ida H Chung; Amy Austin; Jennifer H McQuiston; Erica Weis; Craig Levy; Maria da Gloria S Carvalho; Audrey Mitchell; Adam Bjork; Joanna J Regan
Journal:  Am J Trop Med Hyg       Date:  2014-10-20       Impact factor: 2.345

6.  Self-reported treatment practices by healthcare providers could lead to death from Rocky Mountain spotted fever.

Authors:  Jillian Zientek; F Scott Dahlgren; Jennifer H McQuiston; Joanna Regan
Journal:  J Pediatr       Date:  2013-11-16       Impact factor: 4.406

7.  Intravenous Immunoglobulin Therapy for Cerebral Vasculitis Associated with Rocky Mountain Spotted Fever.

Authors:  H Christine Allen; Robert C Welliver; Monica W Fogarty; Morris Gessouroun; Emilie D Henry
Journal:  J Pediatr Intensive Care       Date:  2016-08-08

8.  Risk factors for fatal outcome from rocky mountain spotted Fever in a highly endemic area-Arizona, 2002-2011.

Authors:  Joanna J Regan; Marc S Traeger; Dwight Humpherys; Dianna L Mahoney; Michelle Martinez; Ginny L Emerson; Danielle M Tack; Aimee Geissler; Seema Yasmin; Regina Lawson; Velda Williams; Charlene Hamilton; Craig Levy; Ken Komatsu; David A Yost; Jennifer H McQuiston
Journal:  Clin Infect Dis       Date:  2015-02-19       Impact factor: 9.079

9.  Evaluation of a Spotted Fever Group Rickettsia Public Health Surveillance System in Tennessee.

Authors:  Mary-Margaret A Fill; Abelardo C Moncayo; Karen C Bloch; John R Dunn; William Schaffner; Timothy F Jones
Journal:  Am J Trop Med Hyg       Date:  2017-07-19       Impact factor: 2.345

10.  Seroprevalence of spotted fever group rickettsiae in canines along the United States-Mexico border.

Authors:  Emily G Pieracci; Juan Diego Perez De La Rosa; Daniel Luna Rubio; Mario Eduardo Solis Perales; Manuel Velasco Contreras; Naomi A Drexler; William L Nicholson; José Javier Pérez De La Rosa; Ida H Chung; Cecilia Kato; Casey Barton Behravesh; María Alejandra Gay Enríquez; Jesús Felipe González Roldan; Margarita E Villarino
Journal:  Zoonoses Public Health       Date:  2019-08-23       Impact factor: 2.954

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.